Daily price updates
What planify offer?
Join our channel partner program
₹500.00
Available in Depository:
NSDL
CDSL
Available for Investment:
Primary
Secondary
RECOMMENDATION
Neutral
Business Type
Traditional Business
Management
Accounting Practice
Profitability
Solvency
Growth
Valuation
RATING
RECOMMENDATION
Neutral
Business Type
Traditional Business
Get detailed information about the Ramaraju
Surgical Cotton Pre IPO shares. In this research report, you will
get to know about Ramaraju
Surgical Cotton Mills Limited Key Ratio data. In addition, get the
Complete details about the Net Profit Growth, Revenue Growth and Book Value
Growth.
Growth in %
0.17%
1 Year
6.29%
3 Year
5.44%
5 Year
The Covid-19 has had a negative impact on the cotton mills and textiles industry, particularly in the first two quarters of FY21. The company's operating revenue fell 4% y-o-y in FY21 compared to FY20. In the spinning division, cotton prices have increased by more than 30% since the beginning of the cotton season. Within three to four months, the prices of several imported cotton kinds, particularly the long staple fiber, had risen by 40% to 75%. The company has demonstrated efficient functioning in the surgical and weaving divisions, which aid to generate the revenues of the company.
Growth in %
112.60%
1 Year
68.34%
3 Year
41.76%
5 Year
The company's net profit increased by 113% y-o-y in FY21 compared to FY20. This was primarily due to the nation's lockdown in the first two quarters of FY21. The company's operating expenses, such as raw material purchases, power costs, and labour expenses, have all decreased.
Growth in %
112.74%
1 Year
68.37%
3 Year
3.73%
5 Year
The EPS of the company has increased 113% y-o-y in FY21 over FY20 due to increase in profit of the company.
Growth in %
69.84%
1 Year
34.72%
2 Year
5.86%
3 Year
Growth in %
43.01%
1 Year
30.92%
3 Year
11.74%
5 Year
EBITDA of the company has increased 53% y-o-y in last three financial years (FY19 to FY21) because of decrease in expenses which eventually happened due to nation lockdowns in last 2 years.
Growth in %
61.14%
1 Year
53.38%
3 Year
15.48%
5 Year
Growth in %
2.13%
1 Year
4.74%
3 Year
5.70%
5 Year
The company's total assets increased 2% y-o-y in FY21 compared to FY20. The company's capital advances have climbed by roughly INR 6 Cr, which is one of the key reasons for this growth. The company's trade receivables have also increased by 36% y-o-y in FY21 over FY20.
Growth in %
238.35%
1 Year
-7.88%
3 Year
41.81%
5 Year
The sharp increase in cash flow from operations of the company in FY 21 is majorly due to efficient utilization of working capital by the company like trade receivables, inventories and much more.
Due to the rise in total equity, the company's D/R ratio has improved over time. From FY19 to FY21, it grew by 108% y-o-y. The firm is bolstering its reserves in preparation for the future.
The company's current ratio has improved by 1% y-o-y over the last six financial years, from FY16 to FY21. The corporation has maintained a regular liquidation position to meet short-term obligations. Short-term borrowings of the company declined roughly 21% y-o-y in FY21 over FY20. Current liabilities of the company likewise decreased 16% y-o-y in FY21 over FY20.
Because the company's interest expense has fallen 9% y-o-y in the last three financial years, the interest coverage ratio has increased 107% from FY 19 to FY 21. In order to cover this type of expense, the corporation has kept sufficient liquidity.
The company was able to boost its operating efficiency in FY21 compared to FY20 due to lower material costs. The company reduced its raw and other material purchases from INR 168.5Cr in FY20 to INR 130Cr in FY21. The large increase in interest expense during FY18 and FY19 resulted in a deterioration in operating efficiency.
The company's ROE increased by 25% y-o-y in FY21 compared to FY20. The company's total equity climbed 15%y-o-y, while its net income increased 113% y-o-y in FY21 over FY20, more than offsetting the rise in equity. Because of the lower expenses, the net income has increased.
The company's ROCE increased by 42 % y-o-y in FY21 compared to FY16. As part of its continuing growth and modernization initiative, the business will invest Rs.25Cr. in total (Spinning Rs. 20Cr., Weaving Rs. 1.50Cr., and Surgical Rs 3.50Cr).
In comparison to FY20, the company's ROA increased by 77% y-o-y in FY21. Total assets increased 2% y-o-y in FY21 over FY20, while net income surged 113% y-o-y in FY21 over FY20, more than offsetting the growth in equity. The net income has increased as a result of fewer expenses.
THE RAMARAJU SURGICAL COTTON MILLS LIMITED Dividend Yield
₹500.00
Available in Depository
NSDL
CDSL
Available for Investment
Primary
Secondary
Management
Accounting Practice
Profitability
Solvency
Growth
Valuation
